Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

1972 • 31,801 citations

The Metabolic Basis of Inherited Disease.

1988 • 7,933 citations

The Metabolic Basis of Inherited Disease

1990 • 4,327 citations

HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY

1986 • 1,989 citations

Obituary. Rupert Samuel Bruce Pearson.

1974 • 760 citations

HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia

1988 • 760 citations

Andrew Moynihan Claye.

1977 • 397 citations

Influence of Pravastatin, a Specific Inhibitor of HMG-CoA Reductase, on Hepatic Metabolism of Cholesterol

1990 • 276 citations

Simvastatin

1990 • 219 citations

Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial Hypercholesterolemia

1987 • 215 citations

Plasma fibrinogen — an independent cardiovascular risk factor

1990 • 199 citations

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

1984 • 176 citations

EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA

1986 • 157 citations

Lovastatin

1988 • 134 citations

Mevinolin Plus Colestipol in Therapy for Severe Heterozygous Familial Hypercholesterolemia

1984 • 132 citations

The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia

1990 • 88 citations

Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia

1990 • 84 citations

Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system.

1991 • 84 citations

Increased Plasma Fibrinogen and Platelet-Aggregates in Type II Hyperlipoproteinaemia

1979 • 75 citations

Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.

1989 • 75 citations

Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions.

1988 • 73 citations

Effects of Simvastatin and Cholestyramine in Familial and Nonfamilial Hypercholesterolemia

1990 • 64 citations

Effect of short-term treatment with bezafibrate on plasma fibrinogen, fibrinopeptide A, platelet activation and blood filterability in atherosclerotic hyperfibrinogenemic patients

1988 • 55 citations

Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol

1989 • 48 citations

COMPARISON BETWEEN SIMVASTATIN AND BEZAFIBRATE IN EFFECT ON PLASMA LIPOPROTEINS AND APOLIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLAEMIA

1988 • 46 citations

Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia

1989 • 45 citations

Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels

1990 • 44 citations

Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system.

1991 • 44 citations

The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia

1990 • 39 citations

Simvastatin in severe hypercholesterolaemia: a placebo controlled trial.

1991 • 36 citations

HMG CoA reductase inhibitors

1991 • 35 citations

Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles

1988 • 33 citations

Safety, Tolerability, and Efficacy of Simvastatin and Fenofibrate - A Multicenter Study

1990 • 32 citations

Increased urinary mevalonic acid excretion in patients with abetalipoproteinemia and homozygous hypobetalipoproteinemia

1989 • 29 citations

A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III

1988 • 29 citations

Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.

1989 • 24 citations

Changes induced by gemfibrozil on lipidic, coagulative and fibrinolytic pattern in patients with type IV hyperlipoproteinemia.

1988 • 24 citations

Lovastatin therapy in heterozygous familial hypercholesterolaemic patients: effect on blood rheology and fibrinogen levels

1991 • 23 citations

DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment

1991 • 15 citations

Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I

1990 • 14 citations